Abstract
1677P Pancreatic enzyme replacement therapy improves survival in patients receiving nab-paclitaxel plus gemcitabine as first-line treatment for advanced pancreatic adenocarcinoma
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have